Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors. [PDF]
Avecilla V +5 more
europepmc +1 more source
An Association between HTRA1 and TGF-β2 in the Vitreous Humor of Patients with Chorioretinal Vascular Diseases. [PDF]
Fukushima Y +9 more
europepmc +1 more source
An Emerging Role of Micro- and Nanoplastics in Vascular Diseases. [PDF]
Lee SE +4 more
europepmc +1 more source
Targeting PDGF/PDGFR Signaling Pathway by microRNA, lncRNA, and circRNA for Therapy of Vascular Diseases: A Narrow Review. [PDF]
Ma CN +6 more
europepmc +1 more source
The role of transcription factors in the pathogenesis and therapeutic targeting of vascular diseases. [PDF]
Hu P, Du Y, Xu Y, Ye P, Xia J.
europepmc +1 more source
Insights to Ang/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases. [PDF]
Sha L +5 more
europepmc +1 more source
Short-term fluctuation of intraocular pressure and influencing factors following intravitreal injection in patients with retinal vascular diseases. [PDF]
Miao JP, Zeng YY, Gu XM, Zhang XY.
europepmc +1 more source
Tortuosity in non-atherosclerotic vascular diseases is associated with age, arterial aneurysms, and hypertension. [PDF]
Luta X +12 more
europepmc +1 more source
Vascular Diseases in Women: Do Women Suffer from Them Differently? [PDF]
Farkas K +15 more
europepmc +1 more source

